Mark Connor

Scopus Author ID ResearcherID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 26

Top Topics

Genome Wide Association

Neuropathic Pain

Lipopolysaccharide Induced

Top Venues

British journal of pharmacology

ACS chemical neuroscience

Nature communications

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Tahira Foyzun, Maddie Whiting, Kate K Velasco, Jessie C Jacobsen, Mark Connor, Natasha L Grimsey
Single nucleotide polymorphisms in the cannabinoid CB 2 receptor: Molecular pharmacology and disease associations. British journal of pharmacology 181 (15) (2024)
Tahira Foyzun, Maddie Whiting, Kate K Velasco, Jessie C Jacobsen, Mark Connor, Natasha L Grimsey
Single nucleotide polymorphisms in the cannabinoid CB 2 receptor: Molecular pharmacology and disease associations. British journal of pharmacology 181 (15) (2024)
Michael Udoh, Marina J Santiago, Syed Haneef, Alison Rodger, Charles K Marlowe, Philip J Barr, Mark Connor
Activation of CB2 Receptors by (-)-Cannabichromene but Not (+)-Cannabichromene. Cannabis and cannabinoid research (2024)
Tahira Foyzun, Maddie Whiting, Kate K Velasco, Jessie C Jacobsen, Mark Connor, Natasha L Grimsey
Single nucleotide polymorphisms in the cannabinoid CB 2 receptor: Molecular pharmacology and disease associations. British journal of pharmacology (2024)
Annukka Kallinen, Karine Mardon, Samuel Lane, Andrew P Montgomery, Rajiv Bhalla, Damion H R Stimson, Muneer Ahamed, Gary J Cowin, David E Hibbs, Eryn L Werry, Roger R Fulton, Mark Connor, Michael Kassiou
Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands. ACS chemical neuroscience (2023)
Somayeh Mirlohi, Chris Bladen, Marina J Santiago, Jonathon C Arnold, Iain McGregor, Mark Connor
Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro. British journal of pharmacology 179 (15) (2022)
Jack Markham, Eric Sparkes, Rochelle Boyd, Shuli Chen, Jamie J Manning, David B Finlay, Felcia Lai, Eila McGregor, Callan J Maloney, Roy R Gerona, Mark Connor, Iain S McGregor, David E Hibbs, Michelle Glass, Richard C Kevin, Samuel D Banister
Defining Steric Requirements at CB 1 and CB 2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues. ACS chemical neuroscience 13 (8) (2022)
Richard C Kevin, Somayeh Mirlohi, Jamie J Manning, Rochelle Boyd, Elizabeth A Cairns, Adam Ametovski, Felcia Lai, Jia Lin Luo, William T Jorgensen, Ross Ellison, Roy R Gerona, David E Hibbs, Iain S McGregor, Michelle Glass, Mark Connor, Chris Bladen, Gerald W. Zamponi, Samuel D Banister
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca V 3) Inhibitors. ACS chemical neuroscience 13 (9) (2022)
Preeti Manandhar, Mark Connor, Marina J Santiago
Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone. Pharmacology research & perspectives 10 (1) (2022)
Xiaohong Yang, Alireza Maleki, Nikolay A Lipey, Xianlin Zheng, Marina Santiago, Mark Connor, Varun K A Sreenivasan, Judith M Dawes, Yiqing Lu, Andrei V Zvyagin
Lifetime-Engineered Ruby Nanoparticles (Tau-Rubies) for Multiplexed Imaging of μ-Opioid Receptors. ACS sensors 6 (3) (2021)
Shivani Sachdev, Samuel D Banister, Marina Santiago, Chris Bladen, Michael Kassiou, Mark Connor
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists. Pharmacology research & perspectives 8 (2) (2021)
Preeti Manandhar, Bridin Patricia Murnion, Natasha L Grimsey, Mark Connor, Marina J Santiago
Do gabapentin or pregabalin directly modulate the µ receptor? PeerJ 9 (2021)
Adam Ametovski, Christa Macdonald, Jamie J Manning, S A Syed Haneef, Marina J Santiago, Lewis J Martin, Eric Sparkes, Andrew Reckers, Roy R Gerona, Mark Connor, Michelle Glass, Samuel D Banister
Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA. ACS chemical neuroscience 11 (21) (2020)
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, Julie Sanchez, Herman D Lim, Claudia Alamein, Preeti Manandhar, Marina J Santiago, Sebastian Fritzwanker, Frank Schmiedel, Timothy A Katte, Tristan A Reekie, Natasha L Grimsey, Michael Kassiou, Barrie Kellam, Cornelius Krasel, Michelle L Halls, Mark Connor, J Robert Lane, Stefan Schulz, Macdonald J Christie, Meritxell Canals
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science signaling 13 (625) (2020)
Samuel D Banister, Richard C Kevin, Lewis Martin, Axel Adams, Christa Macdonald, Jamie J Manning, Rochelle Boyd, Michael Cunningham, Marc Y Stevens, Iain S McGregor, Michelle Glass, Mark Connor, Roy R Gerona
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs. Drug testing and analysis 11 (7) (2019)
Michael Udoh, Marina Santiago, Steven Devenish, Iain S McGregor, Mark Connor
Cannabichromene is a cannabinoid CB2 receptor agonist. British journal of pharmacology 176 (23) (2019)
Samuel D Banister, Jonathon C Arnold, Mark Connor, Michelle Glass, Iain S McGregor
Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol. ACS chemical neuroscience 10 (5) (2019)
Shivani Sachdev, V Kiran Vemuri, Samuel D Banister, Mitchell Longworth, Michael Kassiou, Marina J Santiago, Alexandros Makriyannis, Mark Connor
In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors. British journal of pharmacology 176 (24) (2019)
Annukka Kallinen, Rochelle Boyd, Samuel Lane, Rajiv Bhalla, Karine Mardon, Damion H R Stimson, Eryn L Werry, Roger Fulton, Mark Connor, Michael Kassiou
Synthesis and in vitro evaluation of fluorine-18 benzimidazole sulfones as CB2 PET-radioligands. Organic & biomolecular chemistry 17 (20) (2019)
Samuel D Banister, Axel Adams, Richard C Kevin, Christa Macdonald, Michelle Glass, Rochelle Boyd, Mark Connor, Iain S McGregor, Christopher M Havel, Stephen J Bright, Mireia Ventura Vilamala, Cristina Gil Lladanosa, Monica J Barratt, Roy R Gerona
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Drug testing and analysis 11 (2) (2018)
Marika Heblinski, Christopher Bladen, Mark Connor
Regulation of heterologously expressed 5-HT1B receptors coupling to potassium channels in AtT-20 cells. British journal of pharmacology 176 (3) (2018)
Marjolein Soethoudt, Uwe Grether, Jürgen Fingerle, Travis W Grim, Filomena Fezza, Luciano de Petrocellis, Christoph Ullmer, Benno Rothenhäusler, Camille Perret, Noortje van Gils, David Finlay, Christa MacDonald, Andrea Chicca, Marianela Dalghi Gens, Jordyn Stuart, Henk de Vries, Nicolina Mastrangelo, Lizi Xia, Georgios Alachouzos, Marc P Baggelaar, Andrea Martella, Elliot D Mock, Hui Deng, Laura H Heitman, Mark Connor, Vincenzo Di Marzo, Jürg Gertsch, Aron H Lichtman, Mauro Maccarrone, Pal Pacher, Michelle Glass, Mario van der Stelt
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity. Nature communications 8 (2017)
Phillip Bokiniec, Shila Shahbazian, Stuart J McDougall, Britt A Berning, Delfine Cheng, Ida J Llewellyn-Smith, Peter G R Burke, Simon McMullan, Martina Mühlenhoff, Herbert Hildebrandt, Filip Braet, Mark Connor, Nicolle H Packer, Ann K Goodchild
Polysialic Acid Regulates Sympathetic Outflow by Facilitating Information Transfer within the Nucleus of the Solitary Tract. The Journal of neuroscience : the official journal of the Society for Neuroscience 37 (27) (2017)
Mark S Baker, Seong Beom Ahn, Abidali Mohamedali, Mohammad T Islam, David Cantor, Peter D Verhaert, Susan Fanayan, Samridhi Sharma, Edouard C Nice, Mark Connor, Shoba Ranganathan
Accelerating the search for the missing proteins in the human proteome. Nature communications 8 (2017)
Varun K A Sreenivasan, Wan Aizuddin Wan Razali, Kai Zhang, Rashmi R Pillai, Avishkar Saini, Denitza Denkova, Marina Santiago, Hannah Brown, Jeremy Thompson, Mark Connor, Ewa M Goldys, Andrei V Zvyagin
Development of Bright and Biocompatible Nanoruby and Its Application to Background-Free Time-Gated Imaging of G-Protein-Coupled Receptors. ACS applied materials & interfaces 9 (45) (2017)
William J Redmond, Erin E Cawston, Natasha L Grimsey, Jordyn Stuart, Amelia R Edington, Michelle Glass, Mark Connor
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors. British journal of pharmacology 173 (1) (2015)